These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7360894)

  • 21. A lyoluminescent tissue-equivalent dosemeter for pion therapy beams.
    Atari NA; Malik SR; Brenner DJ; Hilko R; Bradbury JN
    Phys Med Biol; 1983 May; 28(5):493-502. PubMed ID: 6408655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of a negative pion beam in a therapeutic application.
    Richman C
    Radiology; 1975 Jul; 116(1):187-9. PubMed ID: 806098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-equivalent dosemeters for pion therapy beams.
    Shortt KR
    Phys Med Biol; 1984 Mar; 29(3):279-81. PubMed ID: 6709709
    [No Abstract]   [Full Text] [Related]  

  • 24. Dosimetry of beams for negative pi-meson radiation therapy.
    Dicello JF; Fessenden P; Henkelman RM
    Int J Radiat Oncol Biol Phys; 1977; 3():299-306. PubMed ID: 96065
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of Tanderil in radiotherapy].
    Roussel JM; Schoumacher P; Pernot M; Manivit P
    J Radiol Electrol Med Nucl; 1968; 49(1):140-7. PubMed ID: 5662096
    [No Abstract]   [Full Text] [Related]  

  • 26. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
    Parliament M; Alidrisi M; Munroe M; Wolfaardt J; Scrimger R; Thompson H; Field C; Kurien E; Hanson J
    Int J Oral Maxillofac Surg; 2005 Mar; 34(2):114-21. PubMed ID: 15695037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic achievements and developmental prospects of the radiation therapy of malignant tumors].
    Baĭsogolov GD
    Klin Med (Mosk); 1982 Apr; 60(4):3-10. PubMed ID: 6808226
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy.
    Marcié S; Charpiot E; Bensadoun RJ; Ciais G; Hérault J; Costa A; Gérard JP
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1603-6. PubMed ID: 15817369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo beam localization by positron activation in pion therapy.
    Mausner LF; Moinester MA; Knight JD; Cochavi S; Friedland SS
    Radiat Res; 1979 Oct; 80(1):10-23. PubMed ID: 504564
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy planning and dosimetry for the pion applicator at the Swiss Institute for Nuclear Research (SIN).
    Blattmann H
    Radiat Environ Biophys; 1979 Aug; 16(3):205-9. PubMed ID: 116304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pion dose calculations suitable for treatment planning.
    Li GC; Boyd D; Schwettman HA
    Phys Med Biol; 1974 Jul; 19(4):436-77. PubMed ID: 4216912
    [No Abstract]   [Full Text] [Related]  

  • 32. [The applicability of pions to cancer radiotherapy. I. Experimental measurements of the capture and absorption of pions in polymer].
    Maki T; Nakano M; Cho T; Yoshimura A; Yoshinaga H; Uehara S; Hoshi M; Nagoshi C; Onizuka Y; Konishi K
    J UOEH; 1983 Jun; 5(2):221-33. PubMed ID: 6679631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of the therapy planning programs for the 60 beams SIN pion applicator.
    Pedroni E
    Radiat Environ Biophys; 1979 Aug; 16(3):211-7. PubMed ID: 116305
    [No Abstract]   [Full Text] [Related]  

  • 34. Pions for radiotherapy at TRIUMF.
    Skarsgard LD; Henkelman RM; Eaves CJ
    J Can Assoc Radiol; 1980 Mar; 31(1):3-12. PubMed ID: 7364844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical studies of dynamic treatment modes in pion therapy.
    Amols HI; Kittell R; Paciotti MA; Hellend JA; Hogstrom KR; Collier M; Heller P
    Med Phys; 1980; 7(6):621-6. PubMed ID: 7464705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurements at the piE3 single beam correlated to dosimetry and therapy-planning for the pion applicator at SIN.
    Salzmann M
    Radiat Environ Biophys; 1979 Aug; 16(3):219-23. PubMed ID: 116306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Brachytherapy of head and neck cancer].
    Takácsi Nagy Z; Kásler M
    Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the art of in vivo dosimetry.
    Mijnheer B
    Radiat Prot Dosimetry; 2008; 131(1):117-22. PubMed ID: 18765403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A charge collector to determine the stopping distribution of a pion beam.
    Shortt KR; Henkelman RM
    Phys Med Biol; 1978 May; 23(3):495-8. PubMed ID: 674365
    [No Abstract]   [Full Text] [Related]  

  • 40. Basic considerations in simulated treatment planning for the Stanford Medical Pion Generator (SMPG).
    Pistenma DA; Li GC; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):345-56. PubMed ID: 405352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.